@article{a8a51ff45d4746948efe1162c6dd19a3,
title = "Glutathione Primes T Cell Metabolism for Inflammation",
abstract = "Activated T cells produce reactive oxygen species (ROS), which trigger the antioxidative glutathione (GSH) response necessary to buffer rising ROS and prevent cellular damage. We report that GSH is essential for T cell effector functions through its regulation of metabolic activity. Conditional gene targeting of the catalytic subunit of glutamate cysteine ligase (Gclc) blocked GSH production specifically in murine T cells. Gclc-deficient T cells initially underwent normal activation but could not meet their increased energy and biosynthetic requirements. GSH deficiency compromised the activation of mammalian target of rapamycin-1 (mTOR) and expression of NFAT and Myc transcription factors, abrogating the energy utilization and Myc-dependent metabolic reprogramming that allows activated T cells to switch to glycolysis and glutaminolysis. In vivo, T-cell-specific ablation of murine Gclc prevented autoimmune disease but blocked antiviral defense. The antioxidative GSH pathway thus plays an unexpected role in metabolic integration and reprogramming during inflammatory T cell responses.",
keywords = "GSH, Gclc, Myc, NFAT, ROS, T cells, glutathione, glycolysis, mTOR, metabolic reprogramming, metabolism, reactive oxygen species",
author = "Mak, {Tak W.} and Melanie Grusdat and Duncan, {Gordon S.} and Catherine Dostert and Yannic Nonnenmacher and Maureen Cox and Carole Binsfeld and Zhenyue Hao and Anne Br{\"u}stle and Momoe Itsumi and Christian J{\"a}ger and Ying Chen and Olaf Pinkenburg and B{\"a}rbel Camara and Markus Ollert and Carsten Bindslev-Jensen and Vasilis Vasiliou and Chiara Gorrini and Lang, {Philipp A.} and Michael Lohoff and Harris, {Isaac S.} and Karsten Hiller and Dirk Brenner",
note = "Funding Information: We thank L. Soriano Baguet and H. Kurniawan for assistance; L. Wybenga-Groot, C. Fladd, and the SPARC BioCentre in Toronto for Seahorse experiments; A. Elia for assistance with histology; and S. Storn and the Luxembourg Institute of Health's Animal Welfare Structure. We thank M. Saunders for scientific editing and to M. Brenner for general support. D.B. and K.H. are supported by the ATTRACT program and D.B. by a CORE grant (C15/BM/10355103) of the?National Research Fund Luxembourg (FNR). V.V. holds a grant from the NIH NIAAA (5R24AA022057-05). This study was supported by the German Research Council (DFG, SFB974, LA-2558-5/1). M.L. and O.P. are funded by the Deutsches Zentrum f?r Infektionsforschung and the University Hospital Giessen Marburg. T.W.M. holds grants from the National Multiple Sclerosis Society (RG 5035-A-2) and the Canadian Institutes of Health Research (143268, MOP-123276). Publisher Copyright: {\textcopyright} 2017 Elsevier Inc.",
year = "2017",
month = apr,
day = "18",
doi = "10.1016/j.immuni.2017.03.019",
language = "English",
volume = "46",
pages = "675--689",
journal = "Immunity",
issn = "1074-7613",
publisher = "Cell Press",
number = "4",
}